Acurx Pharmaceuticals, Inc. (ACXP)

Acurx Pharmaceuticals Statistics

Total Valuation

ACXP has a market cap or net worth of $8.35 million. The enterprise value is $4.38 million.

Market Cap	8.35M
Enterprise Value	4.38M

Important Dates

The next confirmed earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ACXP has 29.41 million shares outstanding. The number of shares has increased by 26.96% in one year.

Current Share Class	29.41M
Shares Outstanding	29.41M
Shares Change (YoY)	+26.96%
Shares Change (QoQ)	+18.36%
Owned by Insiders (%)	8.75%
Owned by Institutions (%)	6.87%
Float	21.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.97
P/TBV Ratio	3.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.93

Current Ratio	1.93
Quick Ratio	1.86
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -285.79% and return on invested capital (ROIC) is -178.62%.

Return on Equity (ROE)	-285.79%
Return on Assets (ROA)	-106.67%
Return on Invested Capital (ROIC)	-178.62%
Return on Capital Employed (ROCE)	-513.73%
Revenue Per Employee	n/a
Profits Per Employee	-$2.97M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.25% in the last 52 weeks. The beta is -1.27, so ACXP's price volatility has been lower than the market average.

Beta (5Y)	-1.27
52-Week Price Change	-86.25%
50-Day Moving Average	0.44
200-Day Moving Average	0.76
Relative Strength Index (RSI)	32.22
Average Volume (20 Days)	906,493

Short Selling Information

The latest short interest is 638,164, so 2.17% of the outstanding shares have been sold short.

Short Interest	638,164
Short Previous Month	657,629
Short % of Shares Out	2.17%
Short % of Float	2.91%
Short Ratio (days to cover)	0.03

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.87M
Pretax Income	-16.73M
Net Income	-11.87M
EBITDA	n/a
EBIT	-11.87M
Earnings Per Share (EPS)	-$0.69

Balance Sheet

The company has $4.64 million in cash and n/a in debt, giving a net cash position of $4.64 million or $0.16 per share.

Cash & Cash Equivalents	4.64M
Total Debt	n/a
Net Cash	4.64M
Net Cash Per Share	$0.16
Equity (Book Value)	2.31M
Book Value Per Share	0.10
Working Capital	2.31M

Cash Flow

Operating Cash Flow	-9.37M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACXP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.96%
Shareholder Yield	-26.96%
Earnings Yield	-131.53%
FCF Yield	n/a

Analyst Forecast

The average price target for ACXP is $10.00, which is 3,421.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	3,421.13%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1